...
首页> 外文期刊>Journal of cataract and refractive surgery >Intrastromal corneal ring segment SK implantation for moderate to severe keratoconus.
【24h】

Intrastromal corneal ring segment SK implantation for moderate to severe keratoconus.

机译:角膜内角膜环段SK植入治疗中度至重度圆锥角膜。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: To report the efficacy and safety of intrastromal corneal ring segment (ICRS) implantation using a femtosecond laser in the management of advanced keratoconus. SETTING: Private laser center, Toronto, Ontario, Canada. METHOD: In this retrospective nonrandomized study, Intacs SK ICRS were implanted using an IntraLase femtosecond laser in eyes with moderate to severe keratoconus. Evaluation included uncorrected (UDVA) and corrected (CDVA) distance visual acuity, manifest refraction, slitlamp examination, corneal topography, and wavefront analysis of higher-order aberrations. Postoperative visits were at 1, 7, and 30 days and 3 and 6 months. RESULTS: The study evaluated 10 eyes of 8 patients with a mean age of 28 years (range 21 to 42 years). The mean UDVA was significantly better 6 months postoperatively than preoperatively (0.66 logMAR +/- 0.21 [SD] versus 1.19 +/- 0.57 logMAR) (P = .004), as was the mean CDVA (0.25 +/- 0.15 logMAR versus 0.51 +/- 0.20 logMAR) (P = .018). The mean spherical equivalent refractive error was -8.08 diopters (D) preoperatively and -5.03 D at 6 months (P = .65); the mean refractive astigmatism, -5.05 D and -3.90 D, respectively (P = .22); and the mean simulated keratometry value, 57.94 D and 50.07 D, respectively (P = .15). The mean total aberration improved significantly, from 13.48 +/- 4.64 mum preoperatively to 9.42 +/- 1.80 mum postoperatively (P = .007). There were no complications. CONCLUSION: Implantation of ICRS for advanced keratoconus was safe and effective, leading to significant improvement in UDVA, CDVA, and total aberrations. FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned.
机译:目的:报告飞秒激光治疗晚期圆锥角膜的角膜内角膜环节段(ICRS)植入的有效性和安全性。地点:加拿大安大略省多伦多的私人激光中心。方法:在这项回顾性非随机研究中,使用IntraLase飞秒激光将Intacs SK ICRS植入中度至重度圆锥角膜的眼睛。评估包括未矫正(UDVA)和矫正(CDVA)远视力,明显屈光,裂隙灯检查,角膜地形图以及高阶像差的波前分析。术后随访分别为1、7和30天以及3和6个月。结果:该研究评估了8例患者的10眼,平均年龄为28岁(21至42岁)。术后6个月的平均UDVA显着好于术前(0.66 logMAR +/- 0.21 [SD]比1.19 +/- 0.57 logMAR)(P = .004),平均CDVA(0.25 +/- 0.15 logMAR对0.51) +/- 0.20 logMAR)(P = .018)。术前平均球面等效屈光不正为-8.08屈光度(D),6个月时为-5.03 D(P = .65);平均屈光散光分别为-5.05 D和-3.90 D(P = 0.22);和平均模拟角膜曲率测定值分别为57.94 D和50.07 D(P = .15)。平均总像差显着改善,从术前的13.48 +/- 4.64妈妈提高到术后的9.42 +/- 1.80妈妈(P = .007)。没有并发症。结论:植入ICRS治疗晚期圆锥角膜是安全有效的,可显着改善UDVA,CDVA和总像差。财务披露:没有任何作者对所提及的任何材料或方法有财务或所有权利益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号